pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-548w |
Genomic Coordinates | chr16: 26025237 - 26025310 |
Description | Homo sapiens miR-548w stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-548w | |||||||||||||||||||||||||||||||||
Sequence | 10| AAAAGUAACUGCGGUUUUUGCCU |32 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SMAD5 | ||||||||||||||||||||
Synonyms | DWFC, JV5-1, MADH5 | ||||||||||||||||||||
Description | SMAD family member 5 | ||||||||||||||||||||
Transcript | NM_001001419 | ||||||||||||||||||||
Other Transcripts | NM_001001420 , NM_005903 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SMAD5 | |||||||||||||||||||||
3'UTR of SMAD5 (miRNA target sites are highlighted) |
>SMAD5|NM_001001419|3'UTR 1 TGCAGAAGTATTCTTTTCAATTATATTGTTAGTGGACTTGTTTTAATTTTAGAGAAACTTTGAGTACAGATACTGTGAGC 81 TTACATTGAAAACAGATATTACAGCTTATTTTTTTCTACATAATTGTGACCAATACATTTGTATTTTGTGATGAATCTAC 161 ATTTGTTTGTATTCATGTTCATGTGATTAACTCTTAGAAGTGTTGTAAAAGATGCAGAGTAAGTATTATGCCCCAGTTCA 241 GAAATTTGGCATTGATCTTAAACTGGAACATGCTTTTACTTTATTGCCCTAACAATTTTTTATTAAATTTATTTGAAAAT 321 GCATCACATGATGAAAAATTATAGTAGCTTATAAGAGGGCATATACAGTGAAGAGTAAGTTTTCCCTCCTACTCTCGATC 401 TTCCAGAAGCTGTACTTTTACCAGTTTCTTTGTCCCACCAACTTAAAAAAAAAAAGTACAATTCATTGTTTTGCAAAAGT 481 GTATGGTAGGGGCTTAAAAGAAACTATAAAGTTTTATTTGAATGAACACTATGCACTGCTGTAACTGGTAGTGTTCAGTA 561 AAAGCAAAATGATAGTTTTCTAGATGACATAAAATTTACATTTAATACAGATAAGTGTTCTTCAGTGTAATGTGACTTCA 641 TGCTATATATCTTTTGTAAGACATTTCCTTTTTTAAAAAAATTTTTGCAAATAACTGATCTCAAGTATATGTCATTTACT 721 CAAAATCTGTCATAAGCATTACTTTATAGCTAGTGACAGTGCATGCACAGCCTTGTTCAACTATGTTTGCTGCTTTTGGA 801 CAATGTTGCAAGAACTCTATTTTTGACATGCATTAATCTTTTATTTTGCACTTTTATGGGTGACAGTTTTTAGCATAACC 881 TTTGATAAAATACACTCAAGTGACTTGGACTTAGATGCTTATCCTTACGTCCTTGGTACCTTTTTTGTATTAACAAACAC 961 TGCAATTTATAGATTACATTTGTAGGAAGTTATGCTTTTTTCTGGTTTTTGTTTTACTTTCAACCTAGGTTATAAGACTG 1041 TTATTCTATAGCTCCAACTTAAGGTGCCTTTTTAATTCCCTACAGTTTTATGGGTGTTATCAGTGCTGGAGAATCATGTA 1121 GTTAATCCCATTGCTCTTACAAGTGTCAGCTTACTTGTATCAGCCTCCCTACGCAAGGACCTATGCACTGGAGCCGTAGG 1201 AGGCTCTTCAGTTGGGCCCCAAGGATAAGGCTACTGATTTGATACTAAATGAATCAGCAGTGGATGTAGGGATAGCTGAT 1281 TTTAAAACACTCGGCTGGGCACAGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGCAGGCAGATCATGATG 1361 TCAGGAGTTTGAGACCAGCCTGGCCAATATGGTGAAACCCTGTCTCTACAAAAAATACAAAAATTAGCTGGGCATGGTGG 1441 TGCGTGCCTGAAGTCCCAGCTACTCGGGAAGCTGAGGCAGAAGAATCACTTGAACCTGGGAGGCGGAGGTTGTGGTGAGC 1521 CGAGATCGCACCACTGCACTCCAGCCTGGGCGACAGAGCGAGACTCTGCCTCAAAAAACAAAACAAAACAAAACACTCAC 1601 CCATCAACGAATATAGACTCTTCTCTCATTTATCGATGATCCTCTTTTTCCATTTTTTAAGTACTTATGTGGAAGCTAGT 1681 CTCCCAAAACACAATCTTTAGAGAGAAAAGACATGAACGAACTCCAAAATATCCATTTAATCAATCATGTTTTTGGCTTT 1761 GGATAAAGAACTTTGAACCAGTTTTTTTCTCAGGAGCTGTCAAATGGACACTTAATTATGACATGAGAATGAAGAAATTA 1841 TTTTGGAAAAAAAAAATGACCTAATTTACCTATCAGTGAAAGCTTTATTTTCTGGTGCCTTTTGAAAGTATATGGAGTCA 1921 TATCATTCTTCTGTTTAAAATGTTAGTTTGGTTTGACTTTCCACTTTGTCCTTTCTGCTCTTGTGAAGAAAAAAAAAAGC 2001 ATTTTCGAGGAAAGAATTATGCAATTTCTTTTGTTTTCTGTGTCATTATTTATTGCTTTTTCAATGTGCAGCCAGTGGAT 2081 GGTTTTAGTTCTTTCAGATGAACTGCCATTTGTGTTTCAGCTCACAGTTCTTTGCTGGGTAAAAGAAATACTTTCTGACA 2161 GTCACCTGAGCCTTAAATGTAAGTATTACATGACATGCATTCTGTTTCTTCCAGAGTTCTGTCTGCCACACGAAAGAGAA 2241 TATTTGCTTACTTGATAGAACTTTGGCATTTTCATCATTCTTTTACTTAACCAGGCTTATGGCATGATCTCTGGAACAAA 2321 TTTGTAGGAAAAAATTACTCCAATTGAATGACTGATGTATGTAATCAACTTCATTGGGCTGCAGTAAACTAGTGGAAATT 2401 AGAGAGTTGTTTTATTGGTGTTTTCTACTGTGAGTTAATTAAAAATTGTTTTTATTTGGGGTCATTATGTCACAGTCTTG 2481 AGTTAACAAGATCTTACGTGATTGGCCTTTTCTTTGTTTTCTCTTAGGAGTTGTGTCTCATGAATGACAGTACTAAAGCT 2561 ATTAACAACTAAGAGTTTGACAGAGAACTATAAGCCTGTTGTATCTCCTAAAAGTTGTCAACTCCCCACCCTTGGACTTT 2641 AAATGAAAATTTTATTCAGTCCAGCTATTCTTACAGTCCCTAAGGATTTTCATATATCTATGTATAGGAGATAAAATTTG 2721 CTAGTAAGATTTTTAAAAACTGGCTAGTGAAAGGAAAGTACCTCTGAAAGAAACCATTTTAGCAAATTATGGTTATATGT 2801 TTTAATTTAATCTACAGAATGTTTTATAGTAAAATTCTAGCACCACTAGAATAATCACATAGCATGTACAATATATTTAT 2881 GCTGGCTGAAAAGACAGAATCTGGGAATAATAAAATTGCAACCAGTTTGGTAATGCAAACAGCAGAATAGAATGAAATCT 2961 CAGTAATGAATTAAAGCAACAAAAAGATATTGATTGGCAAAAAGCAAGATATAAGAGATTCATTTGCTTAACATTTCTAC 3041 ATAATATTTATGGTCTGGTCAGTATTGGTCTGGTCAGTATTGCCTGGCTGACGTGAAATGTAAACTAGTAGGCGTGTTAT 3121 TGATCTGCTAAAACTAACCCTCTTTTTAAGAGGAGATTTAAGGAAGACGTCAATCAAAATGTCAAATATGTGTGTCAGAA 3201 TATAAATAATTTTTCACATTGTATTGTTGCTATATAAAAAAAATAATAGAATTGGTTGGGTTTCTGAGGTGAAATCCAGA 3281 GTAAGAGTACTAGACAGTTCAACAAGCCACATCTAATGGCACAGATAGAGGATGTAGCTATTTTATACCTTTCATAACAT 3361 TTGAGAGTAAGATATCCTTCAGGATGTGAAGTGATTATTAAGTACTCATACCTGAAATCTGTTGTCAAGATTAGAACTGG 3441 GGTTCATGTTAAAAACCTTCCATATTACCTGAGGGTACCTGTGGGGAACAGTTCCTTCCCCTGTGTGGTAGTATTTTGTT 3521 GGAAGAGAATGTTTATACAAAAAATGAAATTCTTCCAACAGCAGAGAAACTCTAAAAAGTTTGATAGTACCTATCAAAGT 3601 GCTGTACTTCTGTGATAGAGAACATCTGATGTACCAATTTAGATCTATTTCTTTATACTTTTTCTAATCAATTGCTTAAT 3681 AGTACTTTGGATGATTATCACCTTTGCCACTTAAAATATATAAATATCCTTTTTACTTCATGAGGAAGGAAGAATTTTTT 3761 GATAATTACTGAGTTCAGCCTTTTGTGATGACTTATATTTTGGACTTACATTTTAACTTTAAAGAATGTCAGATCCCTTC 3841 TTTGTCTTACTAGTTAAATCCTCACCTAATCTCTTGGGTATGAATATAAATGTGTGTCATCGTTATATTGTTCAGCTAGA 3921 TGAGCAAGTATCTTAGGGTAGTAGGTAGCCTGGTGGTTTTAGAAGTGTTTGGTGATTTTTATGGAGAGAGTTTTCCTAAG 4001 TGGTGGTTTATAGGTGGTATCAGATATTATTAGGGCAGCTTTTTGGGGAGTAATCTCAGGTCTCCCAGAGCAGCAGCATT 4081 TTTCTCATTGATATAAGTAAGATTCTTAGGAGCTTTTCTTATCACACAAGATGCCTGAATCGAATGTGAGAATTGAAGGC 4161 ATTTCTTCTGCATAAACAAAGAATTCTACCTGCTGGACAGAAACCTGGAAAGTTCTTTGGAATTCGCTGAATTACAGTTT 4241 AGTATGTCCTGATTACAGAGTGACAATATTTATCAAGCCTTTGTTATATTGGATTATCTTCTCTCTTAAAATACAACTGT 4321 ATTATAATTGAAATGACAGCCCAAAATTGGATGGTTTACCAAAACCAATGAAAGGGATTTCACACATCAATTTTTATTTC 4401 TGTTTTGAAGAGCACATGCTATATAATAATTGCTAGTAGCAACTGCAGTAAAACAGGTGATAAGTTATTTTCTCTGAAAA 4481 GATCCAGTCCTAGAGCAGGATTCTTCGATCATTCATGGCAGAGTGAAAAAGGTTTGTATGGTTCTTGTCCAAATAACTCA 4561 GTTCTTAAAATTCTTAAAATGATCGTAAACCATTATCCTTTAAAGGTTTATTTGAAGATGCTGTTAAAGTACAGAATTTT 4641 GTGTACAGGTAGATTTTTCCGTCCCTCATTAATAGTGCCTTCTTAATTAATACAGACTGGTGTTAGCTATAACAAAACTC 4721 CAGTAAGGCCAAAGAATCCCAAGTTCTTTGTGGAAAAAAAAAAAAAATCTTTTAGGGTCAGATTTTCCCTTCTAATATCA 4801 TTGAAGATGATGTTGCATTGATTTATTCATAAAGTATTTTAACTATAGGAACTCTAGAAGATAATGGTTAGGCAAGTGAT 4881 TTTTTTTTTAAATATGGTTGGCGTAAGTTGTATTTTGAAATTCACTTATTTTAAAATCGAAGAGGATTGTAATCATGGAA 4961 ATAGAATGTTTGTATCTACCTGCCCACATTTTCTTAAAAAGATATTTCATATACAGATAATGAAGACCAAGCTAGTGGCT 5041 GCACTGTAGGTCTGCTGCTTATTTGTATTTGTTGTGCTTCTGTTTATGTTGTAGAAGCTGAAATTCTAGCAACATGCTTC 5121 AATTCTGTTATTTTGATACTTATGAAAATGTATTAGGTTTTACTATATTGTGCTTTTGAAAGCCATAACTCTTAAGAACT 5201 TTGTTTTTGCATATTGTTTGCTAATTCTTTACTTTAATAAACCTCAAAACCTGC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_005903 | 3UTR | AGCAUUACUUUAUAGCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_001001419 | 3UTR | AGCAUUACUUUAUAGCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_005903 | 3UTR | CUUUAUUGCCCUAACAAUUUUUUAUUAAAUUUAUUUGAAAAUGCAUCACAUGAUGAAAAAUUAUAGUAGCUUAUAAGAGGGCAUAUACAGUGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_005903 | 3UTR | AUUACUUUAUAGCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001001419 | 3UTR | UCUGUCAUAAGCAUUACUUUAUAGCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000545279.1 | 3UTR | CUAAUUCUUUACUUUAAUAAACCUCAAAACCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000545279.1 | 3UTR | CUAAUUCUUUACUUUAAUAAACCUCAAAACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
184 hsa-miR-548w Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT057125 | DDIT4 | DNA damage inducible transcript 4 | 2 | 4 | ||||||||
MIRT063369 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT072492 | RAB8B | RAB8B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT082186 | ACTN4 | actinin alpha 4 | 2 | 6 | ||||||||
MIRT083033 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT085188 | SLC5A3 | solute carrier family 5 member 3 | 2 | 4 | ||||||||
MIRT088905 | FOXN2 | forkhead box N2 | 2 | 4 | ||||||||
MIRT089494 | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 2 | 6 | ||||||||
MIRT092039 | ABHD5 | abhydrolase domain containing 5 | 2 | 2 | ||||||||
MIRT094685 | FEM1C | fem-1 homolog C | 2 | 2 | ||||||||
MIRT095393 | UBE2D2 | ubiquitin conjugating enzyme E2 D2 | 2 | 2 | ||||||||
MIRT096501 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT101296 | FAM135A | family with sequence similarity 135 member A | 2 | 2 | ||||||||
MIRT103356 | CBX3 | chromobox 3 | 2 | 2 | ||||||||
MIRT103872 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT104334 | CLDN12 | claudin 12 | 2 | 2 | ||||||||
MIRT104501 | PEG10 | paternally expressed 10 | 2 | 6 | ||||||||
MIRT111795 | MPZL1 | myelin protein zero like 1 | 2 | 2 | ||||||||
MIRT177238 | BMI1 | BMI1 proto-oncogene, polycomb ring finger | 2 | 2 | ||||||||
MIRT177273 | COMMD3-BMI1 | COMMD3-BMI1 readthrough | 2 | 2 | ||||||||
MIRT177626 | UBE2D1 | ubiquitin conjugating enzyme E2 D1 | 2 | 6 | ||||||||
MIRT178042 | SAMD8 | sterile alpha motif domain containing 8 | 2 | 2 | ||||||||
MIRT179102 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 6 | ||||||||
MIRT179587 | CAPZA1 | capping actin protein of muscle Z-line alpha subunit 1 | 2 | 6 | ||||||||
MIRT195299 | LEPROT | leptin receptor overlapping transcript | 2 | 2 | ||||||||
MIRT203143 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT208430 | ZBTB38 | zinc finger and BTB domain containing 38 | 2 | 2 | ||||||||
MIRT214578 | SMAD5 | SMAD family member 5 | 2 | 4 | ||||||||
MIRT216103 | IL6ST | interleukin 6 signal transducer | 2 | 2 | ||||||||
MIRT216355 | CCNB1 | cyclin B1 | 2 | 4 | ||||||||
MIRT220050 | MDFIC | MyoD family inhibitor domain containing | 2 | 2 | ||||||||
MIRT226729 | ANP32B | acidic nuclear phosphoprotein 32 family member B | 2 | 4 | ||||||||
MIRT227698 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT230071 | SH3BGRL | SH3 domain binding glutamate rich protein like | 2 | 2 | ||||||||
MIRT248637 | HMGN2 | high mobility group nucleosomal binding domain 2 | 2 | 4 | ||||||||
MIRT254790 | XRCC6 | X-ray repair cross complementing 6 | 2 | 6 | ||||||||
MIRT264376 | YAP1 | Yes associated protein 1 | 2 | 2 | ||||||||
MIRT266972 | LRRC55 | leucine rich repeat containing 55 | 2 | 4 | ||||||||
MIRT273949 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT281802 | MAP2K1 | mitogen-activated protein kinase kinase 1 | 2 | 2 | ||||||||
MIRT293252 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT297097 | RGPD4 | RANBP2-like and GRIP domain containing 4 | 2 | 2 | ||||||||
MIRT308170 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT309013 | USP53 | ubiquitin specific peptidase 53 | 2 | 2 | ||||||||
MIRT311470 | PRRC1 | proline rich coiled-coil 1 | 2 | 2 | ||||||||
MIRT312586 | G3BP1 | G3BP stress granule assembly factor 1 | 2 | 4 | ||||||||
MIRT328130 | ZNF711 | zinc finger protein 711 | 2 | 2 | ||||||||
MIRT329313 | FAM53C | family with sequence similarity 53 member C | 2 | 2 | ||||||||
MIRT334642 | NEK7 | NIMA related kinase 7 | 2 | 2 | ||||||||
MIRT340673 | THRAP3 | thyroid hormone receptor associated protein 3 | 2 | 2 | ||||||||
MIRT378858 | ITGB8 | integrin subunit beta 8 | 2 | 2 | ||||||||
MIRT395789 | SPCS3 | signal peptidase complex subunit 3 | 2 | 2 | ||||||||
MIRT405639 | WBP4 | WW domain binding protein 4 | 2 | 4 | ||||||||
MIRT408287 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT442097 | ZNRF2 | zinc and ring finger 2 | 2 | 8 | ||||||||
MIRT442840 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT443116 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT443147 | ZDHHC21 | zinc finger DHHC-type containing 21 | 2 | 2 | ||||||||
MIRT443298 | PRPS1L1 | phosphoribosyl pyrophosphate synthetase 1-like 1 | 2 | 2 | ||||||||
MIRT445080 | ZNF207 | zinc finger protein 207 | 2 | 2 | ||||||||
MIRT445384 | PTCHD1 | patched domain containing 1 | 2 | 4 | ||||||||
MIRT447070 | MCC | mutated in colorectal cancers | 2 | 2 | ||||||||
MIRT447300 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT447512 | MRPS5 | mitochondrial ribosomal protein S5 | 2 | 2 | ||||||||
MIRT449511 | TM6SF1 | transmembrane 6 superfamily member 1 | 2 | 2 | ||||||||
MIRT449902 | C11orf34 | placenta expressed transcript 1 | 1 | 2 | ||||||||
MIRT450551 | SHFM1 | SEM1, 26S proteasome complex subunit | 2 | 2 | ||||||||
MIRT450719 | PVRL3 | nectin cell adhesion molecule 3 | 2 | 2 | ||||||||
MIRT454923 | ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | 2 | 12 | ||||||||
MIRT455892 | KIF2C | kinesin family member 2C | 2 | 2 | ||||||||
MIRT463732 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 2 | 8 | ||||||||
MIRT471182 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT472764 | MTMR6 | myotubularin related protein 6 | 2 | 8 | ||||||||
MIRT474457 | KLHL11 | kelch like family member 11 | 2 | 8 | ||||||||
MIRT475985 | GTPBP2 | GTP binding protein 2 | 2 | 2 | ||||||||
MIRT482277 | AGO2 | argonaute 2, RISC catalytic component | 2 | 4 | ||||||||
MIRT485858 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | 2 | 2 | ||||||||
MIRT486192 | ERH | ERH, mRNA splicing and mitosis factor | 2 | 4 | ||||||||
MIRT488609 | FAM3C | family with sequence similarity 3 member C | 2 | 6 | ||||||||
MIRT489984 | DDB1 | damage specific DNA binding protein 1 | 2 | 2 | ||||||||
MIRT493476 | IPMK | inositol polyphosphate multikinase | 2 | 2 | ||||||||
MIRT494280 | CEP120 | centrosomal protein 120 | 2 | 2 | ||||||||
MIRT497992 | ZBTB20 | zinc finger and BTB domain containing 20 | 2 | 2 | ||||||||
MIRT498473 | PTBP2 | polypyrimidine tract binding protein 2 | 2 | 10 | ||||||||
MIRT498559 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT499867 | SVOP | SV2 related protein | 2 | 10 | ||||||||
MIRT500220 | INHBA | inhibin beta A subunit | 2 | 10 | ||||||||
MIRT500694 | TRIM37 | tripartite motif containing 37 | 2 | 2 | ||||||||
MIRT500988 | SPPL2A | signal peptide peptidase like 2A | 2 | 4 | ||||||||
MIRT501023 | SMG1 | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | 2 | 6 | ||||||||
MIRT502736 | CLIP1 | CAP-Gly domain containing linker protein 1 | 2 | 8 | ||||||||
MIRT502798 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | 2 | 6 | ||||||||
MIRT502887 | CDK4 | cyclin dependent kinase 4 | 2 | 8 | ||||||||
MIRT503483 | ZNF154 | zinc finger protein 154 | 2 | 6 | ||||||||
MIRT503717 | GRM5 | glutamate metabotropic receptor 5 | 2 | 2 | ||||||||
MIRT505137 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT505802 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT505841 | POLR1B | RNA polymerase I subunit B | 2 | 4 | ||||||||
MIRT509284 | NPM3 | nucleophosmin/nucleoplasmin 3 | 2 | 6 | ||||||||
MIRT516829 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT520519 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT520723 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 6 | ||||||||
MIRT525403 | SHISA9 | shisa family member 9 | 2 | 4 | ||||||||
MIRT525867 | ARL13B | ADP ribosylation factor like GTPase 13B | 2 | 2 | ||||||||
MIRT526013 | RBM4B | RNA binding motif protein 4B | 2 | 2 | ||||||||
MIRT526084 | TMEM41B | transmembrane protein 41B | 2 | 2 | ||||||||
MIRT527931 | FRY | FRY microtubule binding protein | 2 | 2 | ||||||||
MIRT528818 | RAB32 | RAB32, member RAS oncogene family | 2 | 2 | ||||||||
MIRT531062 | SLC9A4 | solute carrier family 9 member A4 | 2 | 4 | ||||||||
MIRT535495 | PANX1 | pannexin 1 | 2 | 2 | ||||||||
MIRT536682 | IKZF5 | IKAROS family zinc finger 5 | 2 | 2 | ||||||||
MIRT536835 | HMBOX1 | homeobox containing 1 | 2 | 2 | ||||||||
MIRT537202 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 4 | ||||||||
MIRT537834 | EFNA5 | ephrin A5 | 2 | 2 | ||||||||
MIRT538345 | CSE1L | chromosome segregation 1 like | 2 | 4 | ||||||||
MIRT541242 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT543235 | PEX7 | peroxisomal biogenesis factor 7 | 2 | 2 | ||||||||
MIRT543450 | PARP15 | poly(ADP-ribose) polymerase family member 15 | 2 | 2 | ||||||||
MIRT543711 | XKR9 | XK related 9 | 2 | 2 | ||||||||
MIRT543907 | ESYT1 | extended synaptotagmin 1 | 2 | 2 | ||||||||
MIRT543999 | KLRC3 | killer cell lectin like receptor C3 | 2 | 2 | ||||||||
MIRT544070 | METTL8 | methyltransferase like 8 | 2 | 2 | ||||||||
MIRT544187 | ANGPTL3 | angiopoietin like 3 | 2 | 2 | ||||||||
MIRT544808 | ACSM2B | acyl-CoA synthetase medium chain family member 2B | 2 | 2 | ||||||||
MIRT545046 | PRELID1 | PRELI domain containing 1 | 2 | 2 | ||||||||
MIRT545214 | HIST1H2BD | histone cluster 1 H2B family member d | 2 | 2 | ||||||||
MIRT545289 | SPC25 | SPC25, NDC80 kinetochore complex component | 2 | 2 | ||||||||
MIRT545550 | GIMAP4 | GTPase, IMAP family member 4 | 2 | 2 | ||||||||
MIRT546497 | SIK1 | salt inducible kinase 1 | 2 | 2 | ||||||||
MIRT546914 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT547675 | KPNA1 | karyopherin subunit alpha 1 | 2 | 4 | ||||||||
MIRT547770 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT548687 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT548901 | CHEK2 | checkpoint kinase 2 | 2 | 4 | ||||||||
MIRT549957 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 4 | ||||||||
MIRT550489 | TMEM241 | transmembrane protein 241 | 2 | 2 | ||||||||
MIRT551049 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT552811 | XIAP | X-linked inhibitor of apoptosis | 2 | 4 | ||||||||
MIRT553145 | UBE2H | ubiquitin conjugating enzyme E2 H | 2 | 2 | ||||||||
MIRT553830 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT554258 | SIX4 | SIX homeobox 4 | 2 | 2 | ||||||||
MIRT555781 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 2 | ||||||||
MIRT556318 | MAP2K4 | mitogen-activated protein kinase kinase 4 | 2 | 2 | ||||||||
MIRT556499 | LIPA | lipase A, lysosomal acid type | 2 | 2 | ||||||||
MIRT556693 | KLHL28 | kelch like family member 28 | 2 | 2 | ||||||||
MIRT556752 | KLF7 | Kruppel like factor 7 | 2 | 2 | ||||||||
MIRT556990 | HPRT1 | hypoxanthine phosphoribosyltransferase 1 | 2 | 2 | ||||||||
MIRT557146 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT557487 | GPR27 | G protein-coupled receptor 27 | 2 | 4 | ||||||||
MIRT558102 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 2 | 2 | ||||||||
MIRT559344 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) | 2 | 2 | ||||||||
MIRT560335 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT561299 | ZBTB43 | zinc finger and BTB domain containing 43 | 2 | 2 | ||||||||
MIRT561883 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT561927 | MFSD9 | major facilitator superfamily domain containing 9 | 2 | 2 | ||||||||
MIRT562935 | TNIP2 | TNFAIP3 interacting protein 2 | 2 | 2 | ||||||||
MIRT563291 | BBS10 | Bardet-Biedl syndrome 10 | 2 | 2 | ||||||||
MIRT563405 | KIF3A | kinesin family member 3A | 2 | 2 | ||||||||
MIRT563562 | KIAA1586 | KIAA1586 | 2 | 2 | ||||||||
MIRT565876 | NHS | NHS actin remodeling regulator | 2 | 2 | ||||||||
MIRT566081 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT566396 | PLAGL2 | PLAG1 like zinc finger 2 | 2 | 2 | ||||||||
MIRT567259 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 2 | ||||||||
MIRT571468 | CCDC80 | coiled-coil domain containing 80 | 2 | 2 | ||||||||
MIRT572939 | VDAC2 | voltage dependent anion channel 2 | 2 | 2 | ||||||||
MIRT573628 | ZNF724P | zinc finger protein 724 | 2 | 2 | ||||||||
MIRT573717 | KHSRP | KH-type splicing regulatory protein | 2 | 2 | ||||||||
MIRT609088 | SMIM15 | small integral membrane protein 15 | 2 | 6 | ||||||||
MIRT617936 | EBNA1BP2 | EBNA1 binding protein 2 | 2 | 2 | ||||||||
MIRT618379 | PRKG2 | protein kinase, cGMP-dependent, type II | 2 | 2 | ||||||||
MIRT619627 | PLEKHG7 | pleckstrin homology and RhoGEF domain containing G7 | 2 | 2 | ||||||||
MIRT623455 | KDM5A | lysine demethylase 5A | 2 | 2 | ||||||||
MIRT629145 | CTCFL | CCCTC-binding factor like | 2 | 2 | ||||||||
MIRT638521 | LYRM2 | LYR motif containing 2 | 2 | 2 | ||||||||
MIRT649483 | CLDN16 | claudin 16 | 2 | 2 | ||||||||
MIRT683148 | MTHFD1 | methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 | 2 | 2 | ||||||||
MIRT691660 | SLC43A3 | solute carrier family 43 member 3 | 2 | 2 | ||||||||
MIRT693201 | MKI67 | marker of proliferation Ki-67 | 2 | 2 | ||||||||
MIRT695334 | AQP3 | aquaporin 3 (Gill blood group) | 2 | 2 | ||||||||
MIRT701023 | PCGF5 | polycomb group ring finger 5 | 2 | 2 | ||||||||
MIRT708753 | RYBP | RING1 and YY1 binding protein | 2 | 2 | ||||||||
MIRT717558 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT719286 | SETD7 | SET domain containing lysine methyltransferase 7 | 2 | 2 | ||||||||
MIRT725172 | SDAD1 | SDA1 domain containing 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|